Tokyo, Dec. 25 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000056570) titled 'PGT-M for ABCA3 deficiency' on Dec. 25.
Study Type:
Interventional
Study Design:
Basic Design - Single arm
Randomization - Non-randomized
Blinding - Open -no one is blinded
Control - Uncontrolled
Primary Sponsor:
Institute - Sapporo Medical University of Medicine
Condition:
Condition - ABCA3 deficiency
Classification by malignancy - Others
Genomic information - YES
Objective:
Narrative objectives1 - PGT-M for ABCA3 deficiency
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - PGT-M for ABCA3 deficiency
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Female
Key inclusion criteria - Single Patient
Key exclusion criteria - NA
Target Size - 1
Recruitment Status:
Recruitment status - Enrolling by invitation
Date of protocol fixation - 2024 Year 05 Month 09 Day
Date of IRB - 2024 Year 05 Month 09 Day
Anticipated trial start date - 2024 Year 05 Month 09 Day
Last follow-up date - 2029 Year 03 Month 25 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064650
Disclaimer: Curated by HT Syndication.
